Neuregulin-1 inhibits neuroinflammatory responses in a rat model of organophosphate-nerve agent-induced delayed neuronal injury

BackgroundNeuregulin-1 (NRG-1) has been shown to act as a neuroprotectant in animal models of nerve agent intoxication and other acute brain injuries. We recently demonstrated that NRG-1 blocked delayed neuronal death in rats intoxicated with the organophosphate (OP) neurotoxin diisopropylflurophosphate (DFP). It has been proposed that inflammatory mediators are involved in the pathogenesis of OP neurotoxin-mediated brain damage.MethodsWe examined the influence of NRG-1 on inflammatory responses in the rat brain following DFP intoxication. Microglial activation was determined by immunohistchemistry using anti-CD11b and anti-ED1 antibodies. Gene expression profiling was performed with brain tissues using Affymetrix gene arrays and analyzed using the Ingenuity Pathway Analysis software. Cytokine mRNA levels following DFP and NRG-1 treatment was validated by real-time reverse transcription polymerase chain reaction (RT-PCR).ResultsDFP administration resulted in microglial activation in multiple brain regions, and this response was suppressed by treatment with NRG-1. Using microarray gene expression profiling, we observed that DFP increased mRNA levels of approximately 1,300 genes in the hippocampus 24 h after administration. NRG-1 treatment suppressed by 50% or more a small fraction of DFP-induced genes, which were primarily associated with inflammatory responses. Real-time RT-PCR confirmed that the mRNAs for pro-inflammatory cytokines interleukin-1β (IL-1β) and interleukin-6 (IL-6) were significantly increased following DFP exposure and that NRG-1 significantly attenuated this transcriptional response. In contrast, tumor necrosis factor α (TNFα) transcript levels were unchanged in both DFP and DFP + NRG-1 treated brains relative to controls.ConclusionNeuroprotection by NRG-1 against OP neurotoxicity is associated with the suppression of pro-inflammatory responses in brain microglia. These findings provide new insight regarding the molecular mechanisms involved in the neuroprotective role of NRG-1 in acute brain injuries.

[1]  William Arbuthnot Sir Lane,et al.  ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family , 1993, Cell.

[2]  E. Shohami,et al.  Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  C. Colton.  Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.

[4]  G. Lemercier,et al.  Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound , 2004, Acta Neuropathologica.

[5]  Youichi Kobayashi,et al.  Preventive Effects of Heregulin-&bgr;1 on Macrophage Foam Cell Formation and Atherosclerosis , 2009, Circulation research.

[6]  G. Lallement,et al.  Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain. , 2005, Toxicology.

[7]  Zhenzhong Li,et al.  Neuroprotection by neuregulin-1 in a rat model of permanent focal cerebral ischemia , 2007, Brain Research.

[8]  B. Ford,et al.  Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression , 2005, Neurobiology of Disease.

[9]  A. Bucht,et al.  Soman-Induced Interleukin-1β mRNA and Protein in Rat Brain , 2001 .

[10]  Y. Iso,et al.  Pathogenic involvement of heregulin-β1 in anti-atherogenesis , 2012, Regulatory Peptides.

[11]  R. E. Blair,et al.  Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  F. Tortella,et al.  Quantitative Real-Time RT—PCR Analysis of Inflammatory Gene Expression Associated with Ischemia—Reperfusion Brain Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  J. McDonough,et al.  Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology , 1987, Brain Research.

[14]  M. T. Shipley,et al.  Soman‐induced seizures rapidly activate astrocytes and microglia in discrete brain regions , 1997, The Journal of comparative neurology.

[15]  F. Tortella,et al.  Central neuro-inflammatory gene response following soman exposure in the rat , 2003, Neuroscience Letters.

[16]  Y. S. Lee,et al.  Organophosphate-induced brain injuries: delayed apoptosis mediated by nitric oxide. , 1999, Environmental toxicology and pharmacology.

[17]  J. Loeb,et al.  Following Nerve Injury Neuregulin-1 Drives Microglial Proliferation and Neuropathic Pain via the MEK/ERK Pathway , 2011, Glia.

[18]  M. Waterfield,et al.  Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system , 1993, Nature.

[19]  Hung Li,et al.  Neuregulin-1 reduces ischemia-induced brain damage in rats , 2004, Neurobiology of Aging.

[20]  B. Ford,et al.  Neuregulin-1 is neuroprotective in a rat model of organophosphate-induced delayed neuronal injury. , 2012, Toxicology and applied pharmacology.

[21]  S. Finklestein,et al.  Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke , 2010, Neuropharmacology.

[22]  P. Macdonald,et al.  Parenteral administration of recombinant human neuregulin‐1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses , 2011, European journal of heart failure.

[23]  E. Gilat,et al.  Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[24]  C. Iadecola,et al.  The immunology of stroke: from mechanisms to translation , 2011, Nature Medicine.

[25]  D. Jett.  Neurological aspects of chemical terrorism , 2007, Annals of neurology.

[26]  B. Ford,et al.  Extended Therapeutic Window and Functional Recovery after Intraarterial Administration of Neuregulin-1 after Focal Ischemic Stroke , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  D. Goeddel,et al.  Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.

[28]  E. Gilat,et al.  Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain. , 2006, Neurotoxicology.

[29]  R. Koski,et al.  Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit , 1992, Cell.

[30]  G. De Sarro,et al.  L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. , 1993, European journal of pharmacology.

[31]  E. Lo,et al.  Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice. , 2007, Journal of neurotrauma.

[32]  B. Ford,et al.  Neuregulin-1 Attenuates Neointimal Formation following Vascular Injury and Inhibits the Proliferation of Vascular Smooth Muscle Cells , 2007, Journal of Vascular Research.

[33]  M. Aviram,et al.  Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonase , 1999, Clinical chemistry and laboratory medicine.

[34]  H. Okudera.  Clinical features on nerve gas terrorism in Matsumoto , 2002, Journal of Clinical Neuroscience.

[35]  B. Ford,et al.  Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke. , 2004, Biochemical and biophysical research communications.

[36]  J. Collombet.  Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects. , 2011, Toxicology and applied pharmacology.

[37]  J. Valdés,et al.  A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. , 1991, Toxicology letters.

[38]  B. Ford,et al.  Spatiotemporal pattern of neuronal injury induced by DFP in rats: a model for delayed neuronal cell death following acute OP intoxication. , 2011, Toxicology and applied pharmacology.

[39]  J. Petras.  Neurology and neuropathology of Soman-induced brain injury: an overview. , 1994, Journal of the experimental analysis of behavior.

[40]  A. Bruce-Keller,et al.  The neuregulin GGF2 attenuates free radical release from activated microglial cells , 2003, Journal of Neuroimmunology.

[41]  T Okumura,et al.  The Tokyo subway sarin attack--lessons learned. , 2005, Toxicology and applied pharmacology.

[42]  J. Loeb,et al.  Neuregulin-ErbB Signaling Promotes Microglial Proliferation and Chemotaxis Contributing to Microgliosis and Pain after Peripheral Nerve Injury , 2010, The Journal of Neuroscience.

[43]  Liuquan Cheng,et al.  A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure. , 2010, Journal of the American College of Cardiology.

[44]  B. Ford,et al.  Neuregulin-1 attenuates mortality associated with experimental cerebral malaria , 2014, Journal of Neuroinflammation.

[45]  H. Phillips,et al.  Sensory and Motor Neuron-derived Factor. A NOVEL HEREGULIN VARIANT HIGHLY EXPRESSED IN SENSORY AND MOTOR NEURONS (*) , 1995, The Journal of Biological Chemistry.

[46]  Col. Jonathan Newmark.  The birth of nerve agent warfare , 2004, Neurology.

[47]  McLeod Cg,et al.  Acute neuropathology in soman poisoned rats. , 1984 .

[48]  E. Shohami,et al.  Closed Head Injury Triggers Early Production of TNFα and IL-6 by Brain Tissue , 1994 .

[49]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[50]  J. Meyerhoff,et al.  Transcriptional analysis of rat piriform cortex following exposure to the organophosphonate anticholinesterase sarin and induction of seizures , 2011, Journal of Neuroinflammation.

[51]  Arseny Finkelstein,et al.  A decade after the Tokyo sarin attack: a review of neurological follow-up of the victims. , 2007, Military medicine.

[52]  D. G. Harrington,et al.  Acute neuropathology in soman poisoned rats. , 1984, Neurotoxicology.

[53]  F. Dorandeu,et al.  Prolonged inflammatory gene response following soman-induced seizures in mice. , 2007, Toxicology.

[54]  B. Ford,et al.  Corrigendum to “Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression” [Neurobiol. Dis. 19 (2005) 461–470] , 2008, Neurobiology of Disease.

[55]  H. Morita,et al.  Sarin experiences in Japan: Acute toxicity and long-term effects , 2006, Journal of the Neurological Sciences.

[56]  Erik A. Johnson,et al.  The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations , 2010, Journal of Neuroinflammation.